Patents by Inventor Joshua R. Wurst

Joshua R. Wurst has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HUMAN INTERLEUKIN-4 RECEPTOR ALPHA ANTIBODY GLUCOCORTICOID CONJUGATES
    Publication number: 20240100176
    Abstract: The present disclosure provides human interleukin 4 receptor alpha antibody glucocorticoid receptor agonist conjugates and methods of using the conjugates for the treatment of inflammatory diseases, such as type 2 inflammatory diseases.
    Type: Application
    Filed: May 31, 2023
    Publication date: March 28, 2024
    Inventors: Shane Krummen Atwell, Joshua R Clayton, Yiqing Feng, Maya Rachel Karta, Donmienne Doen Mun Leung, Songqing Na, Kristin Paige Newburn, Laura Anne Pelletier, Diana Isabel Ruiz, David John Stokell, Jacqueline M Wurst, Scott Paul Bauer
  • HUMAN TUMOR NECROSIS FACTOR ALPHA ANTIBODY GLUCOCORTICOID CONJUGATES
    Publication number: 20240082414
    Abstract: The present disclosure provides human tumor necrosis factor alpha antibody glucocorticoid receptor agonist conjugates and methods of using the conjugates for the treatment of autoimmune and inflammatory diseases.
    Type: Application
    Filed: May 5, 2023
    Publication date: March 14, 2024
    Inventors: Grace Chao, Joshua R Clayton, Jordan Scott Crampton, Yiqing Feng, Donmienne Doen Mun Leung, Songqing Na, Kristin Paige Newburn, Scott Charles Potter, Bharathi Ramamurthy, David John Stokell, Jacqueline M. Wurst, Jianghuai Xu
  • N-1 BRANCHED ALKYL SUBSTITUTED IMIDAZO[4,5-C]QUINOLINE COMPOUNDS, COMPOSITIONS, AND METHODS
    Publication number: 20220177471
    Abstract: Imidazo[4,5-c]quinoline compounds having a substituent that is attached at the N-1 position by a branched group, single enantiomers of the compounds, pharmaceutical compositions containing the compounds, and methods of making the compounds are disclosed. Methods of use of the compounds as immune response modifiers, for inducing (or inhibiting) cytokine biosynthesis in humans and animals, and in the treatment of diseases including infectious and neoplastic diseases are also disclosed.
    Type: Application
    Filed: May 27, 2020
    Publication date: June 9, 2022
    Inventors: George W. Griesgraber, Michael J. Rice, Hannah C. Cohen, Devon M. Hunerdosse, Adam D. Miller, Joshua R. Wurst
  • Oil resistant adhesive
    Patent number: 10947423
    Abstract: The present disclosure provides an oil-resistant adhesive comprising a crosslinked copolymer of (meth)acrylic ester monomers, methyl (meth)acrylate monomers, vinyl ester monomers, and a functional monomer selected from one of (meth)acrylic acid, a (meth)acrylamide or a hydroxyalkyl (meth)acrylate monomers.
    Type: Grant
    Filed: February 3, 2017
    Date of Patent: March 16, 2021
    Assignee: 3M Innovative Properties Company
    Inventors: Robert B. Rosner, Joshua R. Wurst, Robert J. Shimanek, III, Rhesa M. Browning, Ann R. Fornof, Dong-Wei Zhu, Adam R. Wohl
  • OIL RESISTANT ADHESIVE
    Publication number: 20190092979
    Abstract: The present disclosure provides an oil-resistant adhesive comprising a crosslinked copolymer of (meth)acrylic ester monomers, methyl (meth)acrylate monomers, vinyl ester monomers, and a functional monomer selected from one of (meth)acrylic acid, a (meth)acrylamide or a hydroxyalkyl (meth)acrylate monomers.
    Type: Application
    Filed: February 3, 2017
    Publication date: March 28, 2019
    Inventors: Robert B. Rosner, Joshua R. Wurst, Robert J. Shimanek, III, Rhesa M. Browning, Ann R. Fornof, Dong-Wei Zhu, Adam R. Wohl
  • Acrylic adhesive composition from protected photocrosslinking agents
    Patent number: 10189771
    Abstract: Protected photocrosslinkers and their use in two-stage photocuring of (meth)acrylate monomers is described.
    Type: Grant
    Filed: January 28, 2016
    Date of Patent: January 29, 2019
    Assignee: 3M Innovative Properties Company
    Inventors: Karl E. Benson, Ross E. Behling, Anish Kurian, Ryan B. Prince, Joshua R. Wurst, Adam R. Wohl, Robert J. Webb, Sehban Ozair
  • ALKYLOXY SUBSTITUTED THIAZOLOQUINOLINES AND THIAZOLONAPHTHYRIDINES
    Publication number: 20180057509
    Abstract: Thiazoloquinolines and thiazolonaphthyridines with an alkoxy substituent at the 6, 7, 8, or 9-position, pharmaceutical compositions containing the compounds, intermediates, methods of making and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.
    Type: Application
    Filed: November 2, 2017
    Publication date: March 1, 2018
    Inventors: RYAN B. PRINCE, BRYON A. MERRILL, PHILIP D. HEPPNER, TUSHAR A. KSHIRSAGAR, JOSHUA R. WURST, KARL J. MANSKE, MICHAEL J. RICE
  • ACRYLIC ADHESIVE COMPOSITION FROM PROTECTED PHOTOCROSSLINKING AGENTS
    Publication number: 20180029970
    Abstract: Protected photocrosslinkers and their use in two-stage photocuring of (meth)acrylate monomers is described.
    Type: Application
    Filed: January 28, 2016
    Publication date: February 1, 2018
    Inventors: Karl E. Benson, Ross E. Behling, Anish Kurian, Ryan B. Prince, Joshua R. Wurst, Adam R. Wohl, Robert J. Webb, Sehban Ozair
  • Alkoxy substituted imidazoquinolines
    Patent number: 9856254
    Abstract: Imidazoquinoline compounds with an alkoxy substituent at the 6, 7, 8, or 9-position, pharmaceutical compositions containing the compounds, intermediates, methods of making, and methods of use of these compounds as immunomodulators, for inducing or inhibiting cytokine biosynthesis in animals and in the treatment of diseases including viral, and neoplastic, are disclosed.
    Type: Grant
    Filed: June 13, 2016
    Date of Patent: January 2, 2018
    Assignee: 3M Innovative Properties Company
    Inventors: Kyle J. Lindstrom, Bryon A. Merrill, Chad A. Haraldson, Michael J. Rice, Tushar A. Kshirsagar, Philip D. Heppner, Joshua R. Wurst, Shri Niwas, Sarah J. Slania
  • ALKYLOXY SUBSTITUTED THIAZOLOQUINOLINES AND THIAZOLONAPHTHYRIDINES
    Publication number: 20170088559
    Abstract: Thiazoloquinolines and thiazolonaphthyridines with an alkoxy substituent at the 6, 7, 8, or 9-position, pharmaceutical compositions containing the compounds, intermediates, methods of making and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.
    Type: Application
    Filed: December 12, 2016
    Publication date: March 30, 2017
    Inventors: RYAN B. PRINCE, BRYON A. MERRILL, PHILIP D. HEPPNER, TUSHAR A. KSHIRSAGAR, JOSHUA R. WURST, KARL J. MANSKE, MICHAEL J. RICE
  • Alkyloxy substituted thiazoloquinolines and thiazolonaphthyridines
    Patent number: 9546184
    Abstract: Thiazoloquinolines and thiazolonaphthyridines with an alkoxy substituent at the 6, 7, 8, or 9-position, pharmaceutical compositions containing the compounds, intermediates, methods of making and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.
    Type: Grant
    Filed: June 8, 2015
    Date of Patent: January 17, 2017
    Assignee: 3M INNOVATIVE PROPERTIES COMPANY
    Inventors: Ryan B. Prince, Bryon A. Merrill, Philip D. Heppner, Tushar A. Kshirsagar, Joshua R. Wurst, Karl J. Manske, Michael J. Rice
  • POLYMERIC COMPOSITIONS AND METHOD OF MAKING AND ARTICLES THEREOF
    Publication number: 20160369069
    Abstract: Described herein is a mixture comprising: (a) a non-self-crosslinking polymer; and (b) a modifying compound comprising: (i) a first functional group capable of reacting with the reaction sites of the non-self-crosslinking polymer; and (ii) a second functional group capable of crosslinking with a curing agent, wherein the first functional group is different than the second functional group. Also, described are curable polymeric compositions, and methods of making cured polymeric compositions.
    Type: Application
    Filed: August 30, 2016
    Publication date: December 22, 2016
    Inventors: Anthony P. Manzara, Michael D. Crandall, Joshua R. Wurst
  • ALKOXY SUBSTITUTED IMIDAZOQUINOLINES
    Publication number: 20160280707
    Abstract: Imidazoquinoline compounds with an alkoxy substituent at the 6, 7, 8, or 9-position, pharmaceutical compositions containing the compounds, intermediates, methods of making, and methods of use of these compounds as immunomodulators, for inducing or inhibiting cytokine biosynthesis in animals and in the treatment of diseases including viral, and neoplastic, are disclosed.
    Type: Application
    Filed: June 13, 2016
    Publication date: September 29, 2016
    Inventors: Kyle J. Lindstrom, Bryon A. Merrill, Chad A. Haraldson, Michael J. Rice, Tushar A. Kshirsagar, Philip D. Heppner, Joshua R. Wurst, Shri Niwas, Sarah J. Slania
  • Alkoxy substituted imidazoquinolines
    Patent number: 9365567
    Abstract: Imidazoquinoline compounds with an alkoxy substituent at the 6, 7, 8, or 9-position, pharmaceutical compositions containing the compounds, intermediates, methods of making, and methods of use of these compounds as immunomodulators, for inducing or inhibiting cytokine biosynthesis in animals and in the treatment of diseases including viral, and neoplastic, are disclosed.
    Type: Grant
    Filed: September 30, 2014
    Date of Patent: June 14, 2016
    Assignee: 3M Innovative Properties Company
    Inventors: Kyle J. Lindstrom, Bryon A. Merrill, Chad A. Haraldson, Michael J. Rice, Tushar A. Kshirsagar, Philip D. Heppner, Joshua R. Wurst, Shri Niwas, Sarah J. Slania
  • ALKYLOXY SUBSTITUTED THIAZOLOQUINOLINES AND THIAZOLONAPHTHYRIDINES
    Publication number: 20150266901
    Abstract: Thiazoloquinolines and thiazolonaphthyridines with an alkoxy substituent at the 6, 7, 8, or 9-position, pharmaceutical compositions containing the compounds, intermediates, methods of making and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.
    Type: Application
    Filed: June 8, 2015
    Publication date: September 24, 2015
    Inventors: RYAN B. PRINCE, BRYON A. MERRILL, PHILIP D. HEPPNER, TUSHAR A. KSHIRSAGAR, JOSHUA R. WURST, KARL J. MANSKE, MICHAEL J. RICE
  • ALKOXY SUBSTITUTED IMIDAZOQUINOLINES
    Publication number: 20150023990
    Abstract: Imidazoquinoline compounds with an alkoxy substituent at the 6, 7, 8, or 9-position, pharmaceutical compositions containing the compounds, intermediates, methods of making, and methods of use of these compounds as immunomodulators, for inducing or inhibiting cytokine biosynthesis in animals and in the treatment of diseases including viral, and neoplastic, are disclosed.
    Type: Application
    Filed: September 30, 2014
    Publication date: January 22, 2015
    Inventors: Kyle J. Lindstrom, Bryon A. Merrill, Chad A. Haraldson, Michael J. Rice, Tushar A. Kshirsagar, Philip D. Heppner, Joshua R. Wurst, Shri Niwas, Sarah J. Slania
  • Alkoxy substituted imidazoquinolines
    Patent number: 8871782
    Abstract: Imidazoquinoline compounds with an alkoxy substituent at the 6, 7, 8, or 9-position, pharmaceutical compositions containing the compounds, intermediates, methods of making, and methods of use of these compounds as immunomodulators, for inducing or inhibiting cytokine biosynthesis in animals and in the treatment of diseases including viral, and neoplastic, are disclosed.
    Type: Grant
    Filed: October 1, 2004
    Date of Patent: October 28, 2014
    Assignee: 3M Innovative Properties Company
    Inventors: Kyle J. Lindstrom, Bryon A. Merrill, Chad A. Haraldson, Michael J. Rice, Tushar A. Kshirsagar, Philip D. Heppner, Joshua R. Wurst, Shri Niwas, Sarah C. Johannessen
  • Method of preferentially inducing the biosynthesis of interferon
    Patent number: 8846710
    Abstract: A method of preferentially inducing IFN-? biosynthesis in an animal comprising administering certain imidazo[4,5-c] ring compounds with a hydroxymethyl or hydroxyethyl substituent at the 2-position or pharmaceutical compositions containing the compounds, intermediates, methods of making, and methods of using these compounds a immunomodulators for treatment of diseases including viral and neoplastic diseases comprising preferentially inducing IFN-? biosynthesis in an animal are disclosed.
    Type: Grant
    Filed: February 22, 2006
    Date of Patent: September 30, 2014
    Assignee: 3M Innovative Properties Company
    Inventors: Tushar A. Kshirsagar, Bryon A. Merrill, Scott E. Langer, Kyle J. Lindstrom, Sarah C. Slania, Gregory J. Marszalek, Joshua R. Wurst, Karl J. Manske, Shri Niwas, Gregory D. Lundquist, Jr., Philip D. Heppner, George W. Griesgraber, Michael E. Danielson
  • POLYMERIC COMPOSITIONS AND METHOD OF MAKING AND ARTICLES THEREOF
    Publication number: 20140187722
    Abstract: Described herein is a composition comprising at least one of: X—R—(Z)n wherein X is selected from: an aziridine amide, an aziridine urea, an isocyanate, an alcohol, an amine, an epoxy, or a sulfhydryl, R is a multifunctional organic group, and Z is selected from —N3 or —C?C—R?, wherein R? is a hydrogen or a monofunctional organic group and n is from one to about 10. Also, described are mixtures, curable polymeric compositions, and methods of making cured polymeric compositions.
    Type: Application
    Filed: March 5, 2014
    Publication date: July 3, 2014
    Applicant: 3M INNOVATIVE PROPERTIES COMPANY
    Inventors: Anthony P. Manzara, Michael D. Crandall, Joshua R. Wurst
  • Polymeric compositions and method of making and articles thereof
    Patent number: 8703877
    Abstract: Described herein is a mixture comprising: a non-self-crosslinking polymer; and a modifying compound comprising at least two different functional groups. The first functional group of the modifying compound is capable of reacting with the non-self-crosslinking polymer and the second functional group is capable of crosslinking with a curing agent. Also, described are compositions, curable polymeric compositions, articles using such curable polymeric compositions, and methods of making cured polymeric compositions.
    Type: Grant
    Filed: November 10, 2010
    Date of Patent: April 22, 2014
    Assignee: 3M Innovative Properties Company
    Inventors: Anthony P. Manzara, Michael D. Crandall, Joshua R. Wurst